Nanoparticles that undergo a localized morphology change
to target
areas of inflammation have been previously developed but are limited
by their lack of biodegradability. In this paper, we describe a low-ring-strain
cyclic olefin monomer, 1,3-dimethyl-2-phenoxy-1,3,4,7-tetrahydro-1,3,2-diazaphosphepine
2-oxide (MePTDO), that rapidly polymerizes via ring-opening metathesis
polymerization at room temperature to generate well-defined degradable
polyphosphoramidates with high monomer conversion (>84%). Efficient
MePTDO copolymerizations with norbornene-based monomers are demonstrated,
including a norbornenyl monomer functionalized with a peptide substrate
for inflammation-associated matrix metalloproteinases (MMPs). The
resulting amphiphilic peptide brush copolymers self-assembled in aqueous
solution to generate micellar nanoparticles (30 nm in diameter) which
exhibit excellent cyto- and hemocompatibility and undergo MMP-induced
assembly into micron-scale aggregates. As MMPs are upregulated in
the heart postmyocardial infarction (MI), the MMP-responsive micelles
were applied to target and accumulate in the infarcted heart following
intravenous administration in a rat model of MI. These particles displayed
a distinct biodistribution and clearance pattern in comparison to
nondegradable analogues. Specifically, accumulation at the site of
MI competed with elimination predominantly through the kidney rather
than the liver. Together, these results suggest this as a promising
new biodegradable platform for inflammation targeted delivery.